Abstract:Blocking inhibitory receptors like PD-1 and CTLA-4 has revolutionized cancer treatment in recent years. However, despite major successes in melanoma and lung cancer, the majority of cancer types are not responsive to these immunotherapies. As such, there is an ongoing need for the identification of novel inhibitory receptors as drug targets. Most inhibitory receptors signal via immunoreceptor tyrosine-based inhibitory motifs (ITIMs) and previous studies have estimated that our genome contains over 1600 ITIM-bearing transmembrane proteins. However, further testing and development of this large number of candidates requires increased understanding of their expression patterns and likelihood to function as inhibitory receptor. To assist in the selection of novel inhibitory receptor as therapeutic targets, we designed a novel bioinformatics pipeline integrating machine learning-guided structural predictions and sequence-based likelihood models to identify 51 known and 390 putative inhibitory receptors. Using publicly available transcriptomics data of immune cells, we determined the expression of these novel inhibitory receptors, and classified them into previously proposed functional categories. Known and putative inhibitory receptors were expressed across a wide variety of immune cells, and we found cell type-specific patterns in expression of these receptors. We used our pipeline to study inhibitory receptor expression patterns in single cell transcriptomics data of tumour infiltrating T cells. We determined that putative immune inhibitory receptors were expressed differentially in CD4 and CD8 T cell subsets, including exhausted CD8 T cells and CD4 memory T cells, which could allow for subset-specific targeting. In conclusion, we present an inhibitory receptor pipeline that identifies 51 known and 390 novel inhibitory receptors. This pipeline will support future drug target selection across diseases where therapeutic targeting of immune inhibitory receptors is warranted.

A Comprehensive Immunoreceptor Phosphotyrosine-based Signaling Network Revealed by Reciprocal Protein-Peptide Array Screening.

Probing the Immunoreceptor Tyrosine-Based Inhibition Motif Interaction Protein Partners with Proteomics

Identification of Human T Cell Receptor Γδ-Recognized Epitopes/Proteins Via CDR3δ Peptide-based Immunobiochemical Strategy

Using Reciprocal Protein-Peptide Array Screening to Unravel Protein Interaction Networks.

Motif-dependent Immune Co-Receptor Interactome Profiling by Photoaffinity Chemical Proteomics.

High-throughput profiling of sequence recognition by tyrosine kinases and SH2 domains using bacterial peptide display

Combinatorial proteomic analysis of intercellular signaling applied to the CD28 T-cell costimulatory receptor

A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome.

Molecular recognition of ITIM/ITSM domains with SHP2 and their allosteric effect

Accurate sequence-to-affinity models for SH2 domains from multi-round peptide binding assays coupled with free-energy regression

Structural basis for the immune recognition and selectivity of the immune receptor PVRIG for ligand Nectin-2

An Auxiliary Binding Interface of SHIP2-SH2 for Y292-phosphorylated FcγRIIB Reveals Diverse Recognition Mechanisms for Tyrosine-Phosphorylated Receptors Involved in Different Cell Signaling Pathways.

A membrane protein display platform for receptor interactome discovery

Defining T cell receptor repertoires using nanovial-based binding and functional screening

Dissecting phospho-motif-dependent Shc1 interactome using long synthetic protein fragments

Massively parallel screening of TIR-derived peptides reveals vast TLR-targeting immunomodulatory peptides

Integrated src kinase and costimulatory activity enhances signal transduction through single-chain chimeric receptors in T lymphocytes

Generating and validating renewable affimer protein binding reagents targeting SH2 domains

Massively Parallel Screening of Toll/Interleukin‐1 Receptor (TIR)‐Derived Peptides Reveals Multiple Toll‐Like Receptors (TLRs)‐Targeting Immunomodulatory Peptides

A novel bioinformatics pipeline for the identification of immune inhibitory receptors as potential therapeutic targets

Interactome Mapping Uncovers a General Role for Numb in Protein Kinase Regulation.